Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 536

1.

Treatment of chronic inflammatory demyelinating polyneuropathy with pulsed oral steroids.

Muley SA, Kelkar P, Parry GJ.

Arch Neurol. 2008 Nov;65(11):1460-4. doi: 10.1001/archneur.65.11.1460.

PMID:
19001164
2.
3.

Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.

Latov N, Deng C, Dalakas MC, Bril V, Donofrio P, Hanna K, Hartung HP, Hughes RA, Merkies IS, van Doorn PA; IGIV-C CIDP Efficacy (ICE) Study Group..

Arch Neurol. 2010 Jul;67(7):802-7. doi: 10.1001/archneurol.2010.105. Epub 2010 May 10.

PMID:
20457948
4.

Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.

Mazlumzadeh M, Hunder GG, Easley KA, Calamia KT, Matteson EL, Griffing WL, Younge BR, Weyand CM, Goronzy JJ.

Arthritis Rheum. 2006 Oct;54(10):3310-8.

5.

Interferon beta-1a as an investigational treatment for CIDP.

Vallat JM, Hahn AF, Léger JM, Cros DP, Magy L, Tabaraud F, Bouche P, Preux PM.

Neurology. 2003 Apr 1;60(8 Suppl 3):S23-8.

PMID:
12707419
6.

Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial.

Nobile-Orazio E, Cocito D, Jann S, Uncini A, Beghi E, Messina P, Antonini G, Fazio R, Gallia F, Schenone A, Francia A, Pareyson D, Santoro L, Tamburin S, Macchia R, Cavaletti G, Giannini F, Sabatelli M; IMC Trial Group..

Lancet Neurol. 2012 Jun;11(6):493-502. doi: 10.1016/S1474-4422(12)70093-5. Epub 2012 May 10.

PMID:
22578914
7.
8.

Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy.

Magda P, Latov N, Brannagan TH 3rd, Weimer LH, Chin RL, Sander HW.

Arch Neurol. 2003 Dec;60(12):1755-9.

PMID:
14676052
9.

Immunoadsorption in patients with chronic inflammatory demyelinating polyradiculoneuropathy with unsatisfactory response to first-line treatment.

Galldiks N, Burghaus L, Dohmen C, Teschner S, Pollok M, Leebmann J, Frischmuth N, Hollinger P, Nazli N, Fassbender C, Klingel R, Benzing T, Fink GR, Haupt WF.

Eur Neurol. 2011;66(4):183-9. doi: 10.1159/000331011. Epub 2011 Sep 3.

PMID:
21912134
10.

Intensified, intermittent, low-dose intravenous cyclophosphamide together with oral alternate-day steroid therapy in lupus nephritis (long-term outcome).

Calguneri M, Ozbalkan Z, Ozturk MA, Apras S, Ertenli AI, Kiraz S.

Clin Rheumatol. 2006 Nov;25(6):782-8. Epub 2006 Mar 18.

PMID:
16547692
11.

Intravenous immunoglobulin is effective in patients with diabetes and with chronic inflammatory demyelinating polyneuropathy: long term follow-up.

Jann S, Bramerio MA, Facchetti D, Sterzi R.

J Neurol Neurosurg Psychiatry. 2009 Jan;80(1):70-3. doi: 10.1136/jnnp.2008.149013. Epub 2008 Sep 3.

PMID:
18768571
12.

Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial.

van Schaik IN, Eftimov F, van Doorn PA, Brusse E, van den Berg LH, van der Pol WL, Faber CG, van Oostrom JC, Vogels OJ, Hadden RD, Kleine BU, van Norden AG, Verschuuren JJ, Dijkgraaf MG, Vermeulen M.

Lancet Neurol. 2010 Mar;9(3):245-53. doi: 10.1016/S1474-4422(10)70021-1. Epub 2010 Feb 2.

PMID:
20133204
13.

Corticosteroids can help distinguish between Guillain-Barré syndrome and first attack of chronic inflammatory demyelinating neuropathy: an illustrative case report.

Alexander KJ, Alshubaili AF, Santhamoorthy P, Sharafuddin KM.

Med Princ Pract. 2008;17(5):422-4. doi: 10.1159/000141510. Epub 2008 Aug 6.

14.

[Steroid therapy and plasmapheresis in chronic inflammatory demyelinating polyradiculoneuropathy: a long-term follow-up study].

Hanaoka N, Hanyu N, Yanagisawa N.

Rinsho Shinkeigaku. 1998 Mar;38(3):208-12. Japanese.

PMID:
9711115
15.

Comparison of pulse and oral steroid in childhood membranoproliferative glomerulonephritis.

Bahat E, Akkaya BK, Akman S, Karpuzoglu G, Guven AG.

J Nephrol. 2007 Mar-Apr;20(2):234-45.

PMID:
17514629
16.

Long term prognosis of chronic inflammatory demyelinating polyneuropathy: a five year follow up of 38 cases.

Kuwabara S, Misawa S, Mori M, Tamura N, Kubota M, Hattori T.

J Neurol Neurosurg Psychiatry. 2006 Jan;77(1):66-70.

17.

Long-term effects of intravenous immunoglobulin in CIDP.

Vucic S, Black K, Baldassari LE, Tick Chong PS, Dawson KT, Cros D.

Clin Neurophysiol. 2007 Sep;118(9):1980-4. Epub 2007 Jun 28.

PMID:
17604689
18.

[Methylprednisolone pulse in treatment of childhood chronic inflammatory demyelinating polyneuropathy].

Rafai MA, Boulaajaj FZ, Sekkat Z, El Moutawakkil B, Slassi I.

Arch Pediatr. 2010 Sep;17(9):1293-9. doi: 10.1016/j.arcped.2010.06.022. Epub 2010 Aug 14. French.

PMID:
20709511
19.

[A quadriplegic patient with chronic inflammatory demyelinating polyneuropathy (CIDP) who responded well to corticosteroids and intravenous immunoglobulin therapy].

Fukae J, Okuma Y, Noda K, Fujishima K, Goto K, Mizuno Y.

No To Shinkei. 2001 Dec;53(12):1115-8. Japanese.

PMID:
11806118
20.

Long-term remission of CIDP after pulsed dexamethasone or short-term prednisolone treatment.

Eftimov F, Vermeulen M, van Doorn PA, Brusse E, van Schaik IN; PREDICT..

Neurology. 2012 Apr 3;78(14):1079-84. doi: 10.1212/WNL.0b013e31824e8f84. Epub 2012 Mar 21.

PMID:
22442436

Supplemental Content

Support Center